(Q83756555)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22454318%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

title

Next-generation sequencing for minimal residual disease monitoring in acute myeloid leukemia patients with FLT3-ITD or NPM1 mutations (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22454318%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

main subject

acute myeloid leukemia

1 reference

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22454318%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

Martijn Brugman

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22454318%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

10

Sebastian Suerbaum

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22454318%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

author name string

Felicitas Thol

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22454318%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

Britta Kölking

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22454318%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

Frederik Damm

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22454318%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

Katarina Reinhardt

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22454318%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

Dirk Reinhardt

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22454318%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

Nils von Neuhoff

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22454318%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

Brigitte Schlegelberger

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22454318%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

Jürgen Krauter

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22454318%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

Arnold Ganser

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22454318%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

Michael Heuser

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22454318%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

publication date

27 March 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22454318%20AND%20SRC:MED&resulttype=core&format=json

Genes, Chromosomes and Cancer

27 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22454318%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

volume

51

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22454318%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22454318%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

page(s)

689-695

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22454318%20AND%20SRC:MED&resulttype=core&format=json

Identification of a novel type of ITD mutations located in nonjuxtamembrane domains of the FLT3 tyrosine kinase receptor

27 January 2020

cites work

1 reference

7 January 2021

Clinical significance of minimal residual disease quantification in adult patients with standard-risk acute lymphoblastic leukemia.

1 reference

7 January 2021

Prognostic impact of minimal residual disease in CBFB-MYH11-positive acute myeloid leukemia

1 reference

7 January 2021

Treatment strategies and long-term results in paediatric patients treated in four consecutive AML-BFM trials

1 reference

7 January 2021

Less toxicity by optimizing chemotherapy, but not by addition of granulocyte colony-stimulating factor in children and adolescents with acute myeloid leukemia: results of AML-BFM 98.

1 reference

7 January 2021

Prognostic significance of activating FLT3 mutations in younger adults (16 to 60 years) with acute myeloid leukemia and normal cytogenetics: a study of the AML Study Group Ulm.

1 reference

7 January 2021

Risk-adapted treatment according to minimal residual disease in adult ALL.

1 reference

7 January 2021

Prospective minimal residual disease monitoring to predict relapse of acute promyelocytic leukemia and to direct pre-emptive arsenic trioxide therapy.

1 reference

7 January 2021

Acute myelogenous leukemia with internal tandem duplication of the Flt3 gene appearing or altering at the time of relapse: a report of two cases.

1 reference

7 January 2021

Insertion of FLT3 internal tandem duplication in the tyrosine kinase domain-1 is associated with resistance to chemotherapy and inferior outcome.

1 reference

7 January 2021

Next-Generation Sequencing Technology Reveals a Characteristic Pattern of Molecular Mutations in 72.8% of Chronic Myelomonocytic Leukemia by Detecting Frequent Alterations in TET2, CBL, RAS, and RUNX1

1 reference

7 January 2021

Studies of FLT3 mutations in paired presentation and relapse samples from patients with acute myeloid leukemia: implications for the role of FLT3 mutations in leukemogenesis, minimal residual disease detection, and possible therapy with FLT3 inhibit

1 reference

7 January 2021

Prognostic value of minimal residual disease quantification by real-time reverse transcriptase polymerase chain reaction in patients with core binding factor leukemias

1 reference

7 January 2021

Monitoring of minimal residual disease in NPM1-mutated acute myeloid leukemia: a study from the German-Austrian acute myeloid leukemia study group

1 reference

7 January 2021

FLT3 length mutations as marker for follow-up studies in acute myeloid leukaemia

1 reference

7 January 2021

Internal tandem duplication of FLT3 in relapsed acute myeloid leukemia: a comparative analysis of bone marrow samples from 108 adult patients at diagnosis and relapse

1 reference

7 January 2021

Size of FLT3 internal tandem duplication has prognostic significance in patients with acute myeloid leukemia

1 reference

7 January 2021

Analysis of FLT3-activating mutations in 979 patients with acute myelogenous leukemia: association with FAB subtypes and identification of subgroups with poor prognosis

1 reference

7 January 2021

Identifiers

DOI

10.1002/GCC.21955

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22454318%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

1 reference